Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wang

Showing results (1-10 of 670) with videos related to

Pageof 67
Sort By:
Cancer Discovery|September 6, 2023
Express Delivery of Next-Generation CAR T Cells with Preserved Naive and Stemness Phenotypes for the Treatment of Aggressive LymphomasMichael Wang
Physical Review. E|May 19, 2021
Effect of boundaries on noninteracting weakly active particles in different geometriesMichael Wang
Oncology (Williston Park, N.Y.)|September 5, 2014
Comparative mechanisms of action of proteasome inhibitorsMichael Wang
Cell Cycle (Georgetown, Tex.)|June 24, 2015
New kid on the block: ONC201 in NHLMichael Wang
Neurosurgery|May 19, 2015
E-dura: A Novel Neural Interface DeviceMichael Wang, John Serak
Cancer Treatment and Research|April 8, 2014
Enteric infectionsMichael Wang, Stuart Johnson
Neurosurgery|July 18, 2014
"Time out" for surgical safety checklists?Michael Wang, John Serak
The American Journal of Psychiatry|May 2, 2019
Explaining Naltrexone's Interference With Ketamine's Antidepressant EffectMichael Wang, Adam Kaplin
Health Services Management Research|June 20, 2019
Managing supply chain uncertainty and risk in the pharmaceutical industryMichael Wang, Ferry Jie
Blood|January 9, 2025
High-risk MCL: recognition and treatmentPreetesh Jain, Michael Wang
Pageof 67

Showing results (1-10 of 670) with videos related to

Sort By:
Pageof 67
Cancer Discovery|September 6, 2023
Express Delivery of Next-Generation CAR T Cells with Preserved Naive and Stemness Phenotypes for the Treatment of Aggressive LymphomasMichael Wang
Physical Review. E|May 19, 2021
Effect of boundaries on noninteracting weakly active particles in different geometriesMichael Wang
Oncology (Williston Park, N.Y.)|September 5, 2014
Comparative mechanisms of action of proteasome inhibitorsMichael Wang
Cell Cycle (Georgetown, Tex.)|June 24, 2015
New kid on the block: ONC201 in NHLMichael Wang
Neurosurgery|May 19, 2015
E-dura: A Novel Neural Interface DeviceMichael Wang, John Serak
Cancer Treatment and Research|April 8, 2014
Enteric infectionsMichael Wang, Stuart Johnson
Neurosurgery|July 18, 2014
"Time out" for surgical safety checklists?Michael Wang, John Serak
The American Journal of Psychiatry|May 2, 2019
Explaining Naltrexone's Interference With Ketamine's Antidepressant EffectMichael Wang, Adam Kaplin
Health Services Management Research|June 20, 2019
Managing supply chain uncertainty and risk in the pharmaceutical industryMichael Wang, Ferry Jie
Blood|January 9, 2025
High-risk MCL: recognition and treatmentPreetesh Jain, Michael Wang
Pageof 67